Archive: Strategies for Remote Auditing of Investigative Sites
Apr 9, 2021, 14:43 PM
Course Id :
21832
Barnett Code :
BI14320
Date :
March 12-19, 2021
Conf Date :
Mar 12, 2021, 03:30 AM
Price :
1195.00
Site License Price :
2195.00
Under federal regulation, sponsors are responsible for ensuring the integrity of safety and efficacy data submitted to the FDA to support their application; they are also responsible for ensuring clinical studies are conducted in accordance with the approved protocol. Audits are an opportunity to assess compliance and not just the quality of data, but the systems that generate that data. This web seminar will highlight the collaborative requirements for facilitating remote auditing and identify key considerations for future studies.
- Review the purpose and process of audits
- Examine critical Clinical Investigator quality systems, subsystems, and processes
- Explore study risk assessments to inform the remote auditing plan
- Discuss the use of technology to verify objective evidence
- Address challenges and potential solutions of virtual audits
- Incorporate new FDA guidance and ISO standards to develop a remote audit process
- Clinical Quality Assurance Auditors
- Clinical Quality and Compliance Professionals
- Clinical Research Associates
- Project Managers
- Medical Monitors
- Regulatory Affairs Professionals
- Clinical Research Coordinators
- Clinical Principal Investigators
- IRB Administrators and Members
Elizabeth Ronk Nelson, M.P.H.
Click here for complete trainer
biographies
Hold
this course at your company! For more information, contact Naila Ganatra at +1
215.413.2471.
Sort order :
2021031200000000
topics :
- Clinical Research
- Drug Safety & Development
series :
- Clinical Trials & Translational Medicine
content Id :
urlAliasnm :